Opus Genetics, Inc.
IRD· Nasdaq
IRDOpus Genetics, Inc.
Filed Nov 8, 2012 · 10-Q · 39 days after period end · 0001140361-12-046272
| Metric | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 |
| Net Income | -$2.99M | -$1.47M | $218.89K |
| EPS Diluted | -$0.03 | -$0.02 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Opus Genetics, Inc. · CIK 1228627 · Engraved from SEC EDGAR
ended Sep 30, 2012 · filed Nov 8, 2012 · 39 d after period end
